Andrew Shugard
Papers
1
Total Citations
30
H-Index
1
About
Andrew Shugard’s research lies at the critical intersection of radiation oncology and medical physics, with a primary focus on improving the precision and safety of stereotactic body radiotherapy (SBRT) for prostate cancer. His most cited work, a 2016 study on interfraction anatomical variability, demonstrated that even small daily changes in patient anatomy—such as rectal filling or prostate motion—can lead to significantly increased rectal doses during SBRT, challenging the assumption that tight planning margins alone ensure safety. This contribution has had a lasting impact on clinical practice, informing adaptive radiotherapy strategies and underscoring the need for real-time image guidance. With 30 citations, this paper remains a key reference for researchers and clinicians navigating the rapid adoption of prostate SBRT. Shugard’s work is notable for its practical relevance: by quantifying risks that were previously underestimated, he has helped shape more robust treatment protocols. His research continues to influence efforts to reduce toxicity while maintaining tumor control, making him a valuable voice in the ongoing evolution of high-precision, hypofractionated radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1